loss-of-function mutation in transformer-2 are transformed into sterile phenotypical males but otherwise develop normally (Baker and Ridge, 1980) . Tra2, together with Tra, regulates not only dsx pre-mRNA splicing but also sex-specific expression of the fruitless gene (Heinrichs et al., 1998) , which controls sexual orientation and courtship behavior . In addition, Tra2 is required for spermatogenesis in the male germ line, where it influences pre-mRNA processing in a Traindependent manner (Mattox and Baker, 1991; Amrein et al., 1994; Hazelrigg and Tu, 1994; Madigan et al., 1996; Mattox et al., 1996) . No functions of Tra2 outside sexual differentiation have so far been discovered in Drosophila. Recently, two human homologs of Tra2, Tra2␣ (Dauwalder et al., 1996) and Tra2␤ (Beil et al., 1997) , have been identified. Using transgenic flies with nonfunctional Tra2, Dauwalder et al. (1996) demonstrated that human Tra2␣ is able to rescue Tra-dependent but not Tra-independent functions. The natural functions of mals and flies, it is possible that human Tra2 proteins serve more general purposes than their Drosophila homolog.
SF2, a nuclear fraction, NF20-40, was also required Previously, we reported the creation of a purine-rich (Tacke and Manley, 1995) . To investigate further the ESE, A3, which consists of three copies of a high-affinity interaction of the enhancer with SR proteins, we used ASF/SF2-binding site (Tacke and Manley, 1995) . Here, an in vitro selection assay in which biotinylated A3 or we report the unexpected identification of a HeLa cell S3 RNA was incubated in NE under splicing conditions, nuclear protein that binds specifically to A3 as one or recovered with avidin agarose, and the bound proteins both of the human Tra2 proteins. Using SELEX (Tuerk then analyzed by Western blots with the monoclonal and Gold, 1990 ) and gel mobility-shift experiments, we antibody mAb104, which recognizes a phosphoepitope find that Tra2␣ and Tra2␤ have indistinguishable RNA in RS domains (Roth et al., 1991) . Surprisingly, a 40 kDa binding specificities and bind preferentially to oligo protein rather than ASF/SF2 was the predominant SR (GAA) sequences, such as are present in A3 and several protein (i.e., a protein recognized by mAb104) selected natural splicing enhancers (e.g., Lavigueur et al., 1993;  by A3 ( Figure 1 , lane 1). Binding to A3 was specific, as Xu et al., 1993; Yeakley et al., 1993) . Splicing assays no binding to S3 could be detected ( Figure 1 , lane 2), with HeLa S100 extracts, which lack Tra2 proteins, indisuggesting that this protein might play an important role cate that they are not required for constitutive splicing in A3-dependent splicing. and cannot replace the essential splicing functions of To test whether the 40 kDa protein selected by A3 SR proteins. However, both Tra2 proteins can activate was the SR protein SRp40, we took advantage of poly-A3-dependent splicing in a sequence-specific manner clonal anti-SRp40 antibodies and the fact that SRp40 when added to limiting amounts of HeLa nuclear excan be selected from NE by its genuine high-affinity tracts and can restore enhancer-dependent splicing that binding site, B1 (Tacke et al., 1997) . As shown in Figure  had been inhibited by excess A3 competitor RNA. To-2, mAb104 generated signals of similar intensities with gether, our data indicate that Tra2␣ and Tra2␤ are sethe 40 kDa protein selected by A3 (lane 2), authentic quence-specific activators of pre-mRNA splicing. The SRp40 selected by B1 (lane 4), and 60 ng of baculovirusTra2 proteins are the first mammalian proteins identified produced SRp40 (lane 6). Recognition by mAb104 was capable of functioning in this manner that are not also abolished in each case by treatment of the samples essential splicing factors, and they thus are likely to play with alkaline phosphatase (CIP) before Western analysis important roles in splicing control.
( (Figure 2 , lanes 9, 11, and 13). Note that Using UV cross-linking assays, we showed previously mAb104 and anti-SRp40 antibodies also recognized an that ASF/SF2 bound specifically to the A3 splicing enunidentified SRp30 protein selected by B1 (Figure 2 , hancer in HeLa nuclear extracts (NE) but not to a similar lanes 4, 10 and 11), as previously reported (Tacke et purine-rich sequence, S3, that did not function as an al., 1997). Our results strongly suggest that the 40 kDa enhancer. Furthermore, our data indicated that ASF/SF2 protein binding to A3 is not SRp40. This conclusion was was necessary but not sufficient for activation of A3-dependent splicing in S100 extracts. In addition to ASF/ corroborated by selection experiments with the nuclear or S3 (lane 5). 8, and 9) or B1 RNA (lanes 4, 5, 10, and 11) and of 60 ng purified SRp40 (lanes 6, 7, 12, and 13). Samples were either untreated (Ϫ) or treated with CIP (ϩ), which abolished recognition by mAb104. Lane 1, fraction of input material. Note that B1 binds an unidentified As shown in Figure 3A, proteins bind specifically to the A3 enhancer.
Is a Tra2 Protein
We next wished to determine the distribution of Tra2 What is the identity of the A3-binding protein? Recent in various subcellular fractions, as this could provide cloning of two mammalian homologs of the Drosophila some insight into the possible function of the proteins. splicing regulator Tra2, Tra2␣ (Dauwalder et al., 1996) However, because of the low affinity of the anti-Tra2 and Tra2␤ (Matsuo et al., 1995; Segade et al., 1996;  antibodies to phosphorylated Tra2 proteins, a highly Beil et al., 1997), revealed that both proteins are highly specific anti-Tra2␤ antibody (see Experimental Procehomologous RS domain proteins with extended stretches dures) was used to address this question. As shown in of RS dipeptide repeats, especially in their N-terminal Figure 3B , Tra2␤ was not detected in S100 (lane 1) but RS domains. Moreover, SRp40, Tra2␣, and Tra2␤ all was readily detected in both NE (lane 2) and NF20-40 have very similar predicted molecular weights and (lane 3). In addition, Tra2␤ was selected by A3 but not amounts of R and S residues. We therefore reasoned S3 from NE (lanes 4 and 5) or NF20-40 (data not shown). that phosphorylated human Tra2 proteins, if present in These results confirm that Tra2␤ can interact specifically HeLa cells, might be recognized by mAb104 and display with a splicing enhancer, and its presence in NF20-40 migration properties similar to SRp40 in SDS/polyacrylbut not S100 is consistent with a possible role in the amide gels. To test whether phosphorylated Tra2 profunction of such elements. teins are recognized by mAb104, His-tagged versions of both proteins (HTra2␣ and HTra2␤) were expressed in and purified from Escherichia coli. Indeed, both HTra2␣ RNA Binding Specificities of Human Tra2␣ and Tra2␤ and HTra2␤, which were not recognized by mAb104 in their unphosphorylated states, reacted strongly with the How do the Tra2 proteins bind to the A3 enhancer? One possibility is that they fortuitously recognize an RNA antibody either after incubation under splicing conditions in NE or S100 or following phosphorylation by the sequence similar to the ASF/SF2 recognition motif present in A3. Alternatively, they could be recruited to the SR protein kinase Clk/Sty (data not shown).
To determine whether the A3-binding protein recogenhancer not by direct RNA binding but by interaction with other proteins (e.g., ASF/SF2), which would be connized by mAb104 was in fact a Tra2 protein, we raised polyclonal antibodies against HTra2␣. The resulting antisistent with their preferential detection by biotin selection as opposed to UV cross-linking. To distinguish bebodies recognized both HTra2␣ and HTra2␤, owing to the high degree of sequence identity between the two tween these possibilities, we decided to ascertain the RNA binding specificities of both proteins and to deterproteins, but not recombinant SRp40 or proteins present in a standard SR protein preparation (data not shown).
mine whether these would be consistent with the idea was observed with all sequences containing either poly(A) or oligo(GAA) but not with R17. Notably, binding was also observed with the sequence A7, containing the ASF/SF2-binding site AGAAGAAC, three copies of which constitute the A3 enhancer. Unlike oligo(GAA), poly(A) appears to be unable to function as a splicing enhancer (Tanaka et al., 1994) , and attempts to recover Tra2 proteins from NE with biotinylated poly(A) RNA were unsuccessful (data not shown). This raises the possibility that authentic Tra2 proteins might not recognize poly(A). To obtain a recombinant Tra2 protein that resembled the authentic protein as closely as possible, untagged Tra2␣ (Tra2␣) was expressed in baculovirus-infected insect cells and purified by classical biochemical methods (see Experimental Procedures). As shown in Figure 4C , this protein bound efficiently to oligo(GAA)-containing sequences (A7, R21, R22) but poorly to the poly(A)-containing sequence T12. We also attempted to purify untagged Tra2␤ from baculovirus-infected insect cells, but for technical reasons only a fraction enriched in Tra2␤ could be prepared (see Experimental Procedures). Therefore, a fusion protein but suspect that it may reflect the presence of the Histag on the recombinant proteins used in this assay. that the proteins bind directly to A3 and perhaps other purine-rich splicing enhancers. To this end, we first performed SELEX with HTra2␣ and HTra2␤ that had been Tra2␣ and Tra2␤ Stimulate A3-Dependent Splicing but Cannot Substitute for the Essential phosphorylated in vitro by Clk/Sty (Tacke et al., 1997) . Selected sequences were inspected after five cycles Splicing Function of SR Proteins Taken together, our results provide evidence that both of selection and amplification. Unexpectedly, all of 20 sequences selected by HTra2␣ contained extended Tra2␣ and Tra2␤ can bind directly to A3 and possibly other purine-rich splicing enhancers. What is the funcstretches of poly(A). In one case, the entire selected sequence consisted of a continuous poly(A) sequence tional significance of this, and how, if at all, do Tra2 proteins function in splicing? An important feature of of 24 adenosine residues (data not shown). Sequences selected by HTra2␤ showed greater variety ( Figure 4A ).
SR proteins is that any one of them is sufficient to complement splicing-deficient S100 extracts for splicing of Although many of them also contained stretches of poly(A), others contained motifs of oligo(GAA), which, remarkat least some substrates containing consensus or nearconsensus splice sites. Based largely on this feature, ably, are also found in A3 and a number of naturally occurring splicing enhancers (e.g., Lavigueur et al., SR proteins have been termed general, essential, or constitutive splicing factors and are thought to be redun-1993; Xu et al., 1993; Yeakley et al., 1993) .
To test the significance of these sequences as binding dant in this assay. We first sought to determine whether Tra2 proteins might have similar functions. Significantly, sites for HTra2␣ and HTra2␤, we performed gel mobilityshift experiments with both proteins. Since no signifiboth Tra2␣ ( Figure 5A , lanes 4 and 5) and GST-Tra2␤ (data not shown) were unable to activate splicing of a cant differences were found between the binding specificities of the two proteins (data not shown), the findings ␤-globin pre-mRNA in S100, although efficient splicing was observed with ASF/SF2 ( Figure 5A , lanes 2 and 3). are exemplified in Figure 4B by an experiment with HTra2␣. Four oligo(GAA)-containing sequences, three
Identical results were obtained with PiP7A RNA (Kohtz et al., 1994) as a substrate (data not shown). We next of which were selected by HTra2␤ (R15, R21, and R22) and one by a truncated version of ASF/SF2 (A7; Tacke tested whether Tra2␣ or Tra2␤ was able to complement S100 for splicing of a pre-mRNA containing the A3 enand Manley, 1995); a poly(A)-containing sequence selected by HTra2␣ (T12); and an HTra2␤-selected sehancer. As a splicing substrate, we used an IgM-based pre-mRNA with a suboptimal pyrimidine tract (Watakabe quence containing neither poly(A) nor oligo(GAA) (R17) were radiolabeled and incubated with 3, 15, or 75 nM et al., 1993) containing the A3 enhancer downstream of the 3Ј splice site (M-A3; see Experimental Procedures). of phosphorylated, repurified HTra2␣. Efficient binding place of A3 will not respond to Tra2. Indeed, neither Tra2␣ nor Tra2␤ activated splicing of M-B3 in limiting amounts of NE ( Figure 6B, lanes 3 and 4) . In contrast, As shown in Figure 5B , SR proteins purified from HeLa stimulation was again observed with the SR proteins, cells (lane 2) and ASF/SF2 (lane 5) were active in this although in this case it was very slight with ASF/SF2 assay, although high concentrations (1 g/assay of SR ( Figure 6B , lanes 5-7; activation likely reflects cooperaproteins or 600 nM ASF/SF2) were required for efficient tion with SRp40 present in NE). Hence, sequence-spesplicing. In addition, ASF/SF2 produced unidentified cific binding of Tra2 to A3 likely plays a role in the activabands, probably reflecting aberrant splice site and/or tion of A3-dependent splicing in NE. branch point usage (lane 5). In contrast to ASF/SF2, To extend the above results, we performed competiTra2␣ (lane 3) and GST-Tra2␤ (lane 4) were inactive. As tion assays in NE, using as competitors the A3, B3, and expected, SC35, which binds the A3 enhancer poorly S3 sequences. As shown in Figure 7A , 5-fold excess (Tacke and Manley, 1995) , was also inactive (lane 6). We of A3 decreased the splicing efficiency of M-A3 in NE conclude that Tra2 proteins cannot carry out essential dramatically (lane 2), while 15-fold excess of B3 had no splicing functions executed by SR proteins, neither with effect (lane 5). S3, which does not function as an enconsensus-type substrates nor with a pre-mRNA conhancer (Tacke and Manley, 1995) , also had no effect as a taining an enhancer with high-affinity binding sites for competitor ( Figure 7A , lanes 6 and 7). Most importantly, Tra2 proteins.
inhibition of A3-dependent splicing by A3 competitor The above results indicate that the human Tra2 homologs, in the absence of SR proteins, are unable to activate enhancer-dependent splicing. However, these findings do not address the possibility that one or both of these proteins might nonetheless play an important role in enhancer-dependent splicing under more physiological conditions. Therefore, we employed an assay in which limiting amounts of NE (e.g., Yeakley et al., 1996) that promoted very little if any splicing of M-A3 were supplemented with Tra2␤, purified Tra2␣, or different SR proteins. Most importantly, both Tra2␣ and Tra2␤ prediction from this is that a related substrate, M-B3, but less effectively than 30 or 120 nM GST-Tra2␤ (␤) (lanes 7 and 8). Only the splicing substrates and mRNA products are shown.
containing the SRp40-dependent B3 enhancer (Tacke RNA could be relieved by Tra2␣ ( Figure 7B , lanes 3 and properties of the proteins. In fact, changing the labeled base from G to A strongly increased the cross-linking 4), GST-Tra2␤ ( Figure 7B , lanes 5 and 6; Figure 7C , lanes 7 and 8), or a combination of both ( Figure 7B, lane 7) . efficiency of Tra2 proteins compared to ASF/SF2 (R. T. and J. L. M., unpublished data), confirming the highDepending on the experiment, 30-120 nM of GST-Tra2␤ was sufficient to restore 50%-100% of the splicing effiaffinity of Tra2 for A3 and also indicating that the proteins recognize the A3 sequence in different ways. The latter ciency obtained in the absence of competitor RNA. ASF/ SF2 was able to partially restore M-A3 splicing inhibited may be expected, as Tra2 and ASF/SF2 differ in the number of RNA-binding domains they contain (one and by A3 ( Figure 7C, lanes 3 and 4) but was significantly less effective than the Tra2 proteins. For example, splicing two, respectively) and do not share significant homology with each other in the RNA-binding regions. This makes efficiencies were similar with 240 nM ASF/SF2 and 30 nM GST-Tra2␤ ( Figure 7C, compare lanes 4 and 7) . SC35 it all the more remarkable that these two splicing factors with related but clearly distinct functions and properties did not restore splicing and in fact further decreased splicing efficiency at higher concentrations ( Figure 7C , recognize very similar RNA sequences. The physiological significance of the related RNA lanes 5 and 6). Together, our results demonstrate that Tra2 proteins can specifically activate A3-dependent binding specificities of ASF/SF2 and Tra2 proteins remains to be determined. However, a previous analysis splicing, likely reflecting their ability to bind the enhancer with high affinity.
of the dsx enhancer is consistent with the possibility that ASF/SF2 and Drosophila Tra2 also possess overlapping RNA binding specificities. Both proteins were shown to Discussion bind the dsx enhancer with 4-to 5-fold lower efficiencies when an 18-base purine-rich element (PRE) was deleted In this paper, we have shown that the human homologs (Lynch and Maniatis, 1995) . The two proteins also bound of the Drosophila Tra2 protein are present in HeLa nuthe isolated PRE, with Drosophila Tra2 showing the highclear extract and, unexpectedly, bind efficiently to a est specificity for this sequence, despite the fact that splicing enhancer consisting of high-affinity binding the PRE lacks a GAA triplet. Whether this reflects the sites for the SR protein ASF/SF2. Both Tra2 proteins fact that the PRE is a low-affinity Tra2-binding site or bound tightly and specifically to RNA sequences conis indicative of a slight difference in binding specificity taining GAA repeats, which are similar both to the ASF/ between Drosophila and human Tra2 proteins is not SF2 consensus recognition motif and to sequences known. The human and Drosophila Tra2 RBDs are 54% found in a number of naturally occurring splicing enidentical. hancers. We have provided evidence that the Tra2 proteins are not required for constitutive splicing but inTra2 Proteins as Mammalian Splicing Regulators stead play an important role in enhancer-mediated Unlike SR proteins, Tra2 proteins appear not to function activation of splicing. Thus, the Tra2 proteins on the one as constitutive splicing factors despite their overall hand appear to play a more restricted role in splicing structural similarities to SR proteins. SR proteins posthan do the structurally related SR proteins, while on sess distinct RNA binding specificities (e.g., Heinrichs the other hand they display properties indicative of a and Baker, 1995; Tacke and Manley, 1995; Tacke et al., critical function in splicing control. 1997) , and their RS domains function redundantly in certain assays in vitro (Chandler et al., 1997) and are RNA Binding Specificities of Tra2 Proteins entirely interchangeable in vivo (J. Wang and J. L. M., Our data suggest that human Tra2 proteins and the SR submitted). This suggests that neither the RNA binding protein ASF/SF2 have overlapping RNA binding specispecificity nor the nature of the RS domain is a decisive ficities. Both Tra2␣ and GST-Tra2␤ recognized the sedeterminant for constitutive splicing activity. In fact, viaquence A7, which was previously obtained by SELEX bility of DT40 cells genetically depleted of ASF/SF2 can with a truncated version of ASF/SF2 lacking its RS dobe rescued by chimeric ASF/SF2 proteins in which the main. A7 contains a perfect match of the ASF/SF2 congenuine RS domain was replaced by either the N-or sensus octamer AGAAGAAC and constitutes a high-C-terminal RS domain of Tra2␣ (J. Wang and J. L. M., affinity binding site for authentic ASF/SF2 (Tacke and submitted), indicating that both Tra2␣ RS domains can . Based on gel-shift assays with A7, we perform the essential functions of the ASF/SF2 RS doestimate that ASF/SF2 and Tra2␣ bind this sequence main. It is, however, possible that the overall domain with similar affinities (i.e., with apparent K D values of organization of Tra2 proteins, which differs from that approximately 50 and 30 nM, respectively). Surprisingly, of SR proteins, is incompatible with a function as a binding of Tra2 proteins present in NE to biotinylated constitutive splicing factor, perhaps by preventing cru-A3 could be readily detected, while binding of ASF/SF2 cial protein-protein interactions with other essential was weak. In contrast, UV cross-linking assays using splicing factors, such as the U1 snRNP 70 kDa protein A3 with radioactively labeled G nucleotides initially sugor U2AF (Wu and Maniatis, 1993; Kohtz et al., 1994 ; Zuo gested that ASF/SF2 bound A3 more efficiently than and . In addition, Tra2 and SR proteins other nuclear proteins, in particular more efficiently than may differ in the way they position themselves on the a 40 kDa protein that likely represented a Tra2 protein RNA. In this context, it is noteworthy that despite their but was previously considered to be SRp40 (Tacke and differences in RNA binding specificities, SR proteins . This discrepancy may reflect the different possess common motifs in their RNA-binding domains, properties of the two assays, different cross-linking effiwhich are characteristic of the family (Birney et al., 1993) but are not shared with Tra2 proteins. ciencies of the two proteins, and/or different binding Unlike M-A3 pre-mRNA, which could be spliced in than ASF/SF2. Thus, in the case of natural enhancers that appear to contain high-affinity Tra2 binding sites S100 with purified SR proteins or ASF/SF2 alone, splicing of another A3-enhancer substrate, GN-A3, required (e.g., Lavigueur et al., 1993; Xu et al., 1993; Yeakley et al., 1993; Ryan and Cooper, 1996; Elrick et al., 1998) , in addition the nuclear fraction NF20-40 (Tacke and Manley, 1995) . It is likely that part of the activity of NF20-the Tra2 proteins likely play important roles in the control of enhancer-dependent splicing patterns in vivo, per-40 is due to the presence of Tra2 proteins in this fraction. However, NF20-40 could not be replaced by Tra2 prohaps by recruiting SR proteins or other factors to the enhancer. Cooperative interactions between Drosophila teins and, in addition, is not essential for M-A3 splicing. Additional factors in NF20-40 are therefore likely reTra2 and SR proteins have been documented (Lynch and Maniatis, 1996) , and there is also evidence that quired by specific features of the GN-A3 substrate other than the enhancer sequence itself. Notable among the human Tra2 proteins can interact with SR proteins (Beil et al., 1997; Shin et al., unpublished data) . differences between the GN-A3 and M-A3-substrates are the closer proximity of the enhancer to the 3Ј splice What are the specific functions of the two Tra2 proteins in vivo? Our data have not revealed functional site in M-A3 and the fact that M-A3 contains a weak 3Ј splice site, while GN-A3 contains a weak 5Ј splice site.
differences between Tra2␣ and Tra2␤. Their RBDs are 85% identical, consistent with our finding that their RNA Previous studies showed that SR proteins present in nuclear extracts bind to purine-rich ESEs (e.g., Lavibinding specificities are indistinguishable. The proteins differ mainly in the N-terminal 49 amino acids and in the gueur et Sun et al., 1993; Ramchatesingh et al., 1995) and are present in enhancer complexes (Stakposition of a polyglycine stretch within their C-terminal RS domains, which otherwise are highly homologous. nis and Reed, 1994). Identification of SR proteins has mainly relied on their size and recognition by mAb104.
One possibility consistent with our data is that the two proteins are functionally redundant in vivo. Alternatively, Our data indicate that it may be difficult to distinguish between human Tra2 proteins and SRp40 with mAb104. the small differences in primary structure may account for potential differences in protein-protein interactions, Recently, Yeakley et al. (1996) reported specific binding of a 40 kDa nuclear extract protein to an enhancer eleincluding with constitutive splicing factors such as SR proteins or with cell-specific factors yet to be discovered. ment consisting of an oligo(GAA)-containing sequence. The authors identified the protein as SRp40 on the basis An important aspect of the function of the Drosophila Tra protein in the regulation of dsx splicing appears to of its reactivity with mAb104, but they were unable to detect binding of SRp40 when using purified SR probe its ability to influence the RNA binding properties of Tra2 through cooperative interaction. Whereas Tra2 teins. Based on these and additional findings, they concluded that SRp40 was recruited to the enhancer by a binds preferentially to the purine-rich element of the dsx enhancer in the absence of Tra, it can also bind to the cofactor or complex present in NE. In the light of our data, it seems likely that the 40 kDa SR protein was one dsx repeats in the presence of Tra Maniatis, 1995, 1996) . It is tempting to postulate a scenario in or both of the human Tra2 proteins rather than SRp40 and that it bound the oligo(GAA) element directly. This which cell-specific factors alter the RNA binding properties of human Tra2 proteins analogous to the Tra/Tra2 conclusion is significant because it questions the view that RBD-containing RS domain proteins can be recooperation in Drosophila. It is also noteworthy that Tra2␤ was initially identified as a factor rapidly induced cruited to splicing complexes independent of their RNA binding activity. A 40 kDa protein in HeLa NE shown to during reoxygenation of astrocytes after hypoxia (Matsuo et al., 1995) and subsequently shown to display be cross-linked by UV to an oligo (GAA)-containing ESE in the cardiac troponin T pre-mRNA probably also repredifferent mRNA expression levels in various mouse tissues (Segade et al., 1996) . These examples raise the sents a human Tra2 protein (Ramchatesingh et al., 1995) .
Several studies have shown that SR proteins, includpossibility that at least in some cases mammalian Tra2 proteins themselves might act as stage-specific regulaing ASF/SF2 and SRp40, can participate in the activation of ESE-dependent splicing in vitro (Sun et al., 1993;  tors of pre-mRNA splicing. As in Drosophila, in vivo genetic studies may ultimately be required to elucidate Ramchatesingh et al., 1995; Tacke and Manley, 1995; Yeakley et al., 1996; Tacke et al., 1997) . Although in most the precise roles of mammalian Tra2 proteins in the control of cell-and stage-specific splicing patterns. instances nuclear extracts containing Tra2 were used, in one case SR proteins were shown to activate ESEdependent splicing in S100 extracts (Ramchatesingh et Experimental Procedures al., 1995) . This is consistent with our results and sug-generation of a recombinant baculovirus using the BAC-TO-BAC XbaI (A3) or AluI (B3). Competitor RNAs were prepared by T7 transcription of previously described template plasmids (Tacke and expression system (GIBCO BRL). To express GST-Tra2␤ the coding region was inserted blunt into the BamHI site of pGEX-2T (PharManley, 1995; Tacke et al., 1997) linearized with XbaI and quantitated by trace-labeling with (␣ 32 P)-GTP in parallel transcription reactions, macia).
assuming that transcription efficiency was the same in the presence and absence of the labeled nucleotide. In vitro splicing was perPurification of Recombinant Proteins formed essentially as described (Tacke and Manley, 1995) . For comHis-tagged recombinant proteins were expressed in BL21, purified petition assays, competitor RNA was added together with the subunder denaturing conditions by Ni 2ϩ agarose chromatography, and strate to the splicing reaction. To relieve competition, Tra2 or SR renatured by dialysis (Tacke and Manley, 1995) . GST-tagged proproteins were added last. teins were expressed in JM101 and purified under nondenaturing conditions by glutathione agarose chromatography as described (Xiao and Manley, 1997) . SR proteins from HeLa cells and recombiAcknowledgments nant SR proteins expressed in baculovirus-infected Sf9 cells were purified as previously described (Tacke et al., 1997 (Zahler et al., 1992) , the homogenate was cleared sion. This work was supported by a grant from the National Institutes by centrifugation at 10,000 ϫ g for 30 min, ammonium sulfate was of Health (GM 48259). added to 40% saturation, and precipitation was allowed to proceed for 30-60 min. The soluble material was recovered by centrifugation Received January 22, 1998; revised February 18, 1998. at 10,000 ϫ g, and up to 15 mg was loaded onto a 1 ml Phenyl Superose column (TosoHaas) using the FPLC system (Pharmacia). Bound material was eluted with a linear salt gradient of 1. 
Phosphorylation of Recombinant Proteins
Burtis, K.C. (1993) . The regulation of sex determination and sexually Two hundred micrograms of His-tagged proteins was incubated dimorphic differentiation in Drosophila. Curr. Opin. Cell Biol. 5, 1006-with 20 g of GST-Clk as described previously (Colwill et al., 1996) 1014. and repurified by Ni 2ϩ agarose chromatography as described above. Cá ceres, J.F., Stamm, S., Helfman, D.M., and Krainer, A.R. (1994) . GST-Tra2␤ was phosphorylated in S100 under standard splicing Regulation of alternative splicing in vivo by overexpression of antagconditions for 30 min (Tacke et al., 1997) and repurified as described onistic splicing factors. Science 265, 1706-1709. above.
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